ANIP
ANI Pharmaceuticals Inc (ANIP)
Healthcare • NASDAQ • $81.86-2.44%
- Symbol
- ANIP
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $81.86
- Daily Change
- -2.44%
- Market Cap
- $1.86B
- Trailing P/E
- 20.94
- Forward P/E
- 7.60
- 52W High
- $99.50
- 52W Low
- $56.71
- Analyst Target
- $110.63
- Dividend Yield
- N/A
- Beta
- 0.46
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Company websiteResearch ANIP on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.